<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Questri</title>
	<atom:link href="http://www.questri.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.questri.com</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Mon, 01 Apr 2013 20:02:42 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2</generator>
		<item>
		<title>Quest and Dr. Ellenbogen featured in local news story on Alzheimer&#8217;s and Parkinson&#8217;s Disease&#8230;&#8230;</title>
		<link>http://www.questri.com/uncategorized/quest-and-dr-ellenbogen-featured-in-local-news-story-on-alzheimers-and-parkinsons-disease/</link>
		<comments>http://www.questri.com/uncategorized/quest-and-dr-ellenbogen-featured-in-local-news-story-on-alzheimers-and-parkinsons-disease/#comments</comments>
		<pubDate>Tue, 29 May 2012 16:02:23 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=1336</guid>
		<description><![CDATA[Read story here]]></description>
			<content:encoded><![CDATA[<p><a href="http://detroit.cbslocal.com/2012/05/24/farmington-hills-clinic-fighting-alzheimers-parkinsons/">Read story here<br />
	</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/quest-and-dr-ellenbogen-featured-in-local-news-story-on-alzheimers-and-parkinsons-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GlaxoSmithKline and XenoPort Receive FDA Approval for Horizant(TM) as new treatment for moderate-to-severe primary Restless Legs Syndrome</title>
		<link>http://www.questri.com/uncategorized/glaxosmithkline-and-xenoport-receive-fda-approval-for-horizanttm-as-new-treatment-for-moderate-to-severe-primary-restless-legs-syndrome/</link>
		<comments>http://www.questri.com/uncategorized/glaxosmithkline-and-xenoport-receive-fda-approval-for-horizanttm-as-new-treatment-for-moderate-to-severe-primary-restless-legs-syndrome/#comments</comments>
		<pubDate>Tue, 01 Nov 2011 13:24:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=1229</guid>
		<description><![CDATA[QUEST was the top accruing site for this national clinical program &#8211; thanks to all of our participants! You made a difference! Read more]]></description>
			<content:encoded><![CDATA[<p>QUEST was the top accruing site for this national clinical program &#8211; thanks to all of our participants! You made a difference!</p>
<p><a href="http://phx.corporate-ir.net/phoenix.zhtml?c=187883&amp;p=irol-newsArticle_Print&amp;ID=1547555&amp;highlight=" target="_blank">Read more<br />
	</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/glaxosmithkline-and-xenoport-receive-fda-approval-for-horizanttm-as-new-treatment-for-moderate-to-severe-primary-restless-legs-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More positive data from a clinical trial at QUEST&#8230;</title>
		<link>http://www.questri.com/uncategorized/more-positive-data-from-a-clinical-trial-at-quest/</link>
		<comments>http://www.questri.com/uncategorized/more-positive-data-from-a-clinical-trial-at-quest/#comments</comments>
		<pubDate>Fri, 15 Apr 2011 14:31:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=1084</guid>
		<description><![CDATA[&#160; Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis]]></description>
			<content:encoded><![CDATA[<p>&nbsp;</p>
<p><a href="http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp#guid=20110415005451en&amp;source=RSS_2011&amp;page=1" target="_blank"><span style="font-size: 14px;"><span style="font-family: trebuchet ms,helvetica,sans-serif;"><b><b><b><b><b><b><b><b>Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis</b></b></b></b></b></b></b></b></span></span></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/more-positive-data-from-a-clinical-trial-at-quest/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data in Phase III Program</title>
		<link>http://www.questri.com/uncategorized/biosante-pharmaceuticals-reports-positive-libigel%c2%ae-safety-data-in-phase-iii-program/</link>
		<comments>http://www.questri.com/uncategorized/biosante-pharmaceuticals-reports-positive-libigel%c2%ae-safety-data-in-phase-iii-program/#comments</comments>
		<pubDate>Mon, 14 Feb 2011 16:40:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=1014</guid>
		<description><![CDATA[click here to read this story]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.businesswire.com/news/home/20110212005014/en/BioSante-Pharmaceuticals-Reports-Positive-LibiGel%C2%AE-Safety-Data" target="_blank">click here to read this story<br />
	</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/biosante-pharmaceuticals-reports-positive-libigel%c2%ae-safety-data-in-phase-iii-program/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Impax Pharmaceuticals Announces IPX066 Demonstrates Efficacy and Safety in APEX-PD Phase III Study in Treatment of Early Parkinson&#8217;s Disease</title>
		<link>http://www.questri.com/uncategorized/impax-pharmaceuticals-announces-ipx066-demonstrates-efficacy-and-safety-in-apex-pd-phase-iii-study-in-treatment-of-early-parkinsons-disease/</link>
		<comments>http://www.questri.com/uncategorized/impax-pharmaceuticals-announces-ipx066-demonstrates-efficacy-and-safety-in-apex-pd-phase-iii-study-in-treatment-of-early-parkinsons-disease/#comments</comments>
		<pubDate>Mon, 22 Nov 2010 14:22:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=911</guid>
		<description><![CDATA[Click here for details.]]></description>
			<content:encoded><![CDATA[<p>Click <a href="http://phx.corporate-ir.net/phoenix.zhtml?c=67240&amp;p=irol-newsArticle&amp;ID=1498190&amp;highlight=" target="_blank">here</a> for details.<a href="http://phx.corporate-ir.net/phoenix.zhtml?c=67240&amp;p=irol-newsArticle&amp;ID=1498190&amp;highlight=" target="_blank"><br />
	</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/impax-pharmaceuticals-announces-ipx066-demonstrates-efficacy-and-safety-in-apex-pd-phase-iii-study-in-treatment-of-early-parkinsons-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BOTOX(R) (onabotulinumtoxinA) FDA Approved as Prophylactic Treatment Option for Adult Chronic Migraine Sufferers</title>
		<link>http://www.questri.com/uncategorized/botoxr-onabotulinumtoxina-fda-approved-as-prophylactic-treatment-option-for-adult-chronic-migraine-sufferers/</link>
		<comments>http://www.questri.com/uncategorized/botoxr-onabotulinumtoxina-fda-approved-as-prophylactic-treatment-option-for-adult-chronic-migraine-sufferers/#comments</comments>
		<pubDate>Thu, 04 Nov 2010 13:15:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=908</guid>
		<description><![CDATA[QUEST Research Institute participated in the pivotal study leading to this FDA approval. Click here to read more]]></description>
			<content:encoded><![CDATA[<p>QUEST Research Institute participated in the pivotal study leading to this FDA approval. Click <a href="http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=519281" target="_blank">here</a> to read more</p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/botoxr-onabotulinumtoxina-fda-approved-as-prophylactic-treatment-option-for-adult-chronic-migraine-sufferers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>U of Windsor research could halt advance of Parkinson&#8217;s</title>
		<link>http://www.questri.com/uncategorized/u-of-windsor-research-could-halt-advance-of-parkinsons/</link>
		<comments>http://www.questri.com/uncategorized/u-of-windsor-research-could-halt-advance-of-parkinsons/#comments</comments>
		<pubDate>Fri, 21 May 2010 17:18:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=868</guid>
		<description><![CDATA[U of Windsor research could halt advance of Parkinson&#8217;s.]]></description>
			<content:encoded><![CDATA[<p><a href='http://www.calgaryherald.com/health/Windsor+research+could+halt+advance+Parkinson/2032445/story.html'>U of Windsor research could halt advance of Parkinson&#8217;s</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/u-of-windsor-research-could-halt-advance-of-parkinsons/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Midland Daily News &#8211; Young Onset PD Support Group</title>
		<link>http://www.questri.com/uncategorized/midland-daily-news-young-onset-pd-support-group/</link>
		<comments>http://www.questri.com/uncategorized/midland-daily-news-young-onset-pd-support-group/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 18:25:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=816</guid>
		<description><![CDATA[Mid-Michigan Young Onset Parkinson&#39;s Support Group is on the move! read more&#8230; http://www.ourmidland.com/accent/article_76cf16c4-a453-5ec2-b397-5f2a283b5570.html &#160;]]></description>
			<content:encoded><![CDATA[<p>
	Mid-Michigan Young Onset Parkinson&#39;s Support Group is on the move! read more&#8230;</p>
<p><a href="http://www.ourmidland.com/accent/article_76cf16c4-a453-5ec2-b397-5f2a283b5570.html" target="_blank">http://www.ourmidland.com/accent/article_76cf16c4-a453-5ec2-b397-5f2a283b5570.html<br />
	</a></p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/midland-daily-news-young-onset-pd-support-group/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Parkinson&#8217;s Research Fair &#8211; June 25, 2010</title>
		<link>http://www.questri.com/uncategorized/parkinsons-disease-research-fair-june-25-2010/</link>
		<comments>http://www.questri.com/uncategorized/parkinsons-disease-research-fair-june-25-2010/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 15:15:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=807</guid>
		<description><![CDATA[Quest Research will&#160; be partnering with the Michigan Parkinson&#39;s Foundation, the Parkinson&#39;s Disease Foundation, and National Institute of Health (NIH) at a Parkinson&#39;s Research Fair. This event is free to attend and will feature numerous learning opportunities on PD and research. Click here for more details.]]></description>
			<content:encoded><![CDATA[<p>Quest Research will&nbsp; be partnering with the Michigan Parkinson&#39;s Foundation, the Parkinson&#39;s Disease Foundation, and National Institute of Health (NIH) at a Parkinson&#39;s Research Fair. This event is free to attend and will feature numerous learning opportunities on PD and research. Click <a href="http://www.questri.com/pdfair">here</a> for more details.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/parkinsons-disease-research-fair-june-25-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical Research Studies Gain Popularity Among Uninsured, Unemployed</title>
		<link>http://www.questri.com/uncategorized/clinical-research-studies-gain-popularity-among-uninsured-unemployed/</link>
		<comments>http://www.questri.com/uncategorized/clinical-research-studies-gain-popularity-among-uninsured-unemployed/#comments</comments>
		<pubDate>Tue, 02 Feb 2010 03:31:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.questri.com/?p=506</guid>
		<description><![CDATA[QUEST Research Institute featured on Metro Detroit Evening News on Ruth to the Rescue.&#160; read news story here]]></description>
			<content:encoded><![CDATA[<p>QUEST Research Institute featured on Metro Detroit Evening News on Ruth to the Rescue.&nbsp;</p>
<p><a href="http://www.clickondetroit.com/money/19395695/detail.html" onclick="window.open(this.href, '', 'resizable=no,status=no,location=no,toolbar=no,menubar=no,fullscreen=no,scrollbars=no,dependent=no'); return false;">read news story here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.questri.com/uncategorized/clinical-research-studies-gain-popularity-among-uninsured-unemployed/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
